Please login to the form below

Are you using Patient-Reported Outcomes (PROs) in your oncology trials? If not, why not?

A recent blog, published by Sarah Tressel Gary and Rinah Yamamoto called “Patient-Reported Outcome Data in Oncology Trials - Part 2: Clinical Benefit and Patient Preference”, has sparked our interest. This blog has been written to provide commentary on a topical issue relating to the use of Patient-Reported Outcomes (PROs) in oncology trials.

The authors of this blog presented the findings from several studies (Basch et al., 2016/2017; Denis & Basch et al., 2019) which showed improved health-related quality of life (HRQoL) and overall survival in cancer patients when completing electronic PROs. One of the studies concluded that patients are more engaged when self-reporting their symptoms.

The blog then went on to discuss the findings of a preference study implemented by ERT (a global healthcare company) designed to establish where patients prefer to complete their PROs (at home vs at clinic), how important it is to them to report their symptoms on a daily basis and their preferences on how to report them (electronic diary, directly to their doctor, paper diary,  not at all). The findings from this study showed that the majority of cancer patients would prefer to report their symptoms daily than not at all when enrolled in a clinical trial. It was also shown that a larger proportion of patients preferred to report these daily symptoms electronically and most patients preferred to fill the PROs in the comfort of their own home.

As a result of research like this, regulatory agencies are endorsing the use of PROs to be used more in oncology trials as well as taking them into account when assessing the clinical benefit of oncology products.

This blog addresses the importance of using PROs in oncology trials and the benefits it has to clinical outcomes.


Basch E, et al. Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. J Clin Oncol. 2016 Feb 20;34(6):557-65.

Basch E, et al. Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment. 2017 Jul 11;318(2):197-198.

Denis F, Basch E et al. Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer. JAMA. 2019 Jan 22;321(3):306-307.

Pink divider

OPEN VIE is a global, technology enabled, evidence and access consultancy, with a focus on patient centricity. We work with you to understand, demonstrate and communicate value to inspire change. Our Patient Centred Outcome (PCO) research group within OPEN VIE specialise in the generation of data that matter to patients. We look at the data from the patient and/or their family members/friends’ perspective to enable the scientifically robust measurement of disease, treatment benefit or unmet need.

If you would be interested to know how OPEN VIE can help with patient centred data projects, please contact:

Catherine Bottomley, Director of PCO, OPEN VIE

27th November 2019


Company Details

OPEN Health

+44 1628 481112

Contact Website

The Weighbridge
Brewery Courtyard
High Street
United Kingdom

Latest content on this profile

OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients
OPEN Health
Spotlight interview: 15 minutes on healthcare communications in gene therapy
Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy
OPEN Health
OPEN Health becomes sponsor of MedComms Networking
New for 2020, OPEN Health is pleased to announce its sponsorship of MedComms Networking
OPEN Health
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications
OPEN Health
Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications
OPEN Health
Generating data on long-term outcomes with gene and other advanced therapies
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’.
OPEN Health